Decreased Free Protein S Levels in Polycythemia Vera

• References

• 1 Schafer AI. Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984; 64: 1-12
• 2 Grossi A, Rosseti S, Vannucci AM, Rafanelli D, Rossi FerriniP. Occurrence of haemorrhagic and thrombotic events in myeloproliferative disorders: a retrospective study of 108 patients. Clin Lab Haematol 1988; 10: 167-175
• 3 Pearson TC. Haematocrit, blood viscosity, cerebral blood flow, and vascular occlusion. In: Clinical Aspects of Blood Viscosity and Cell Deformability Lowe G DO. (ed) Springer Verlag; Berlin: 1981: 97-107
• 4 Barbui T, Cortelazzo SS, Viero P, Bassan R, Dini E, Semeraro N. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function. Eur J Cancer Clin Oncol 1983; 19: 1593-1599
• 5 Tartaglia AP, Goldberg JD, Silverstein MN, Dresch C, Tatarsky I, Pisciotta AV, Faguet G, Rosenthal D, Conjalka M, Donovan PB, Berk PD, Wassermann LR. Aspirin and persantine do not prevent thrombotic complications in patients with polycythemia vera treated with phlebotomy. Blood 1981; 58 (Suppl. 01) 240
• 6 Thommen D, Buhrfeind E, Felix R, Sulzer I, Furlan M, Lämmle B. Hämostaseparameter bei 55 Patienten mit venösen und/oder arteriel-len Thromboembolien. Schweiz Med Wochenschr 1989; 119: 493-499
• 7 Berlin NI. Diagnosis and classification of the polycythemias. Semin Hematol 1975; 12: 339-351
• 8 Martinoli JL, Stocker K. Fast functional protein C assay using Protac, a novel protein C activator. Thromb Res 1986; 43: 253-264
• 9 Schwarz HP, Heeb MJ, Lämmle B, Berrettini M, Griffin JH. Quantitative immunoblotting of plasma and platelet protein S. Thromb Haemostas 1986; 56: 382-386
• 10 Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-1352
• 11 Conlan MG, Haire WD. Low protein S in essential thrombocythemia with thrombosis. Am J Hematol 1989; 32: 88-93